Rivaroxaban (XARELTO) now also approved for acute coronary syndrome

Linaclotide (CONSTELLA) for irritable bowel syndrome with constipation

Rheumatoid arthritis: biological versus classic DMARDs

Shortened antibiotic treatment due to rebate contract?

URO-VAXOM against recurrent urinary tract infection?

First endpoint study with an incretin-based antidiabetic is negative

Now official: no codeine for children

Bone growth factor dibotermin alfa (INDUCTOS, INFUSE) - paid opinion leaders, ghostwriting, data manipulation and insufficient evidence of benefit

Medical sales representatives without control

Hydroxyl ethyl starch shall be withdrawn from the market

Renal failure with gyrase inhibitors

The Federal Institute for Drugs and Medical Devices (BfArM) and FUMADERM (dimethyl fumarate and monoethyl fumarates): poor risk management

Finally: restrictions in the use of flupirtine (KATADOLON, generics)

MUTAFLOR (E. coli Nissle) against sun allergy?

© arznei-telegramm 7/2013